Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

CNS & Neurological Disorders - Drug Targets , Volume 15 - Number 1






A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.

, 15(1): 35 - 44

Domenico De Berardis, Laura Orsolini, Nicola Serroni, Gabriella Girinelli, Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis, Monica Mazza, Alessandro Valchera, Michele Fornaro, Giampaolo Perna, Monica Piersanti, Marco Di Nicola, Marilde Cavuto, Giovanni Martinotti and Massimo Di Giannantonio


DOI: 10.2174/1871527314666150821103825


Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis

, 15(1): 45 - 53

Ahmed Negida, Ahmed Menshawy, Gehad El Ashal, Yasmin Elfouly, Yasmein Hani, Yasmin Hegazy, Samar El ghonimy, Samar Fouda and Yomna Rashad


DOI: 10.2174/1871527314666150821103306



Folic Acid Can Contribute to Memory Deficit and Na+, K+- ATPase Failure in the Hippocampus of Adolescent Rats Submitted to Hypoxia- Ischemia

, 15(1): 64 - 72

Jaqueline Vieira Carletti, Bruna Ferrary Deniz, Joseane Jiménez Rojas, Patrícia Maidana Miguel, Janaína Kolling, Emilene Barros Scherer, Angela Teresinha de Souza Wyse, Carlos Alexandre Netto and Lenir Orlandi Pereira


DOI: 10.2174/1871527315666151110125227






Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound

, 15(1): 102 - 107

Margarita E. Neganova, Sergei G. Klochkov, Svetlana V. Afanasieva, Tatiana P. Serkova, Ekaterina S. Chudinova, Sergei O. Bachurin, V. Prakash Reddy, Gjumrakch Aliev and Elena F. Shevtsova


DOI: 10.2174/1871527314666150821111812






Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

How to write and publish your papers in high impact journalsOctober Health DaysCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog